The global Inhalation and Nasal Spray Market will be worth USD 44.36 billion by 2027, according to a current analysis by Emergen Research. An increasing number of patients are suffering from COPD and asthma because of which the sales figures of nasal sprays and generic inhalers in likely to grow within the forecasted span. Consumers prefer nasal route as an alternate to injections or pills. Nasal sprays are mainly used for treating local health problems like rhinitis and nasal congestion.
Article source: https://www.emergenresearch.com/industry-report/inhalation-and-nasal-spray-market